cyanopindolol has been researched along with dihydroalprenolol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McNeel, RL; Mersmann, HJ | 1 |
| Doran, AR; Fregeau, DR; Gietzen, DW; Goodman, TA; Graf, K; Maddock, RJ; Magliozzi, JR; Weiler, PG | 1 |
| Kusiak, JW; Pitha, J | 1 |
3 other study(ies) available for cyanopindolol and dihydroalprenolol
| Article | Year |
|---|---|
Ligand binding to the porcine adipose tissue beta-adrenergic receptor.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Dihydroalprenolol; Guanosine Triphosphate; Kinetics; Ligands; Molecular Conformation; Pindolol; Propanolamines; Receptors, Adrenergic, beta; Swine; Temperature; Time Factors | 1992 |
Beta receptor density in human lymphocyte membranes: changing with aging?
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aging; Binding Sites; Cell Membrane; Cyclic AMP; Dihydroalprenolol; Female; Humans; Lymphocytes; Male; Middle Aged; Norepinephrine; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta | 1991 |
A bromoacetylated analogue of cyanopindolol: an irreversible antagonist at rat beta-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Animals; Binding, Competitive; Brain; Dihydroalprenolol; Erythrocytes; Lung; Metabolic Clearance Rate; Myocardium; Pindolol; Rats; Receptors, Adrenergic, beta; Time Factors | 1987 |